Devicemakers Question CMS' Need To Re-Prove the Efficacy of MRIs

摘要

In its first step toward covering MRIs for patients with implanted pacemakers or cardio-verter defibrillators, the Centers for Medicare & Medicaid Services (CMS) may be overly pre scriptive in the type of clinical trials it will cover, cardiac-device makers say.